Ribback, S.; Sailer, V.; Böhning, E.; Günther, J.; Merz, J.; Steinmüller, F.; Utpatel, K.; Cigliano, A.; Peters, K.; Pilo, M.G.;
et al. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. Int. J. Mol. Sci. 2016, 17, 1618.
https://doi.org/10.3390/ijms17101618
AMA Style
Ribback S, Sailer V, Böhning E, Günther J, Merz J, Steinmüller F, Utpatel K, Cigliano A, Peters K, Pilo MG,
et al. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. International Journal of Molecular Sciences. 2016; 17(10):1618.
https://doi.org/10.3390/ijms17101618
Chicago/Turabian Style
Ribback, Silvia, Verena Sailer, Enrico Böhning, Julia Günther, Jaqueline Merz, Frauke Steinmüller, Kirsten Utpatel, Antonio Cigliano, Kristin Peters, Maria G. Pilo,
and et al. 2016. "The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models" International Journal of Molecular Sciences 17, no. 10: 1618.
https://doi.org/10.3390/ijms17101618
APA Style
Ribback, S., Sailer, V., Böhning, E., Günther, J., Merz, J., Steinmüller, F., Utpatel, K., Cigliano, A., Peters, K., Pilo, M. G., Evert, M., Calvisi, D. F., & Dombrowski, F.
(2016). The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. International Journal of Molecular Sciences, 17(10), 1618.
https://doi.org/10.3390/ijms17101618
